Fruquintinib Plus Toripalimab Is an Effective Third-Line Treatment of Advanced Colorectal Cancer | Docwire News

Fruquintinib combined with the anti-programmed death-1 antibody toripalimab is effective in treating advanced colon cancer.

Read the full article here

Related Articles